SYA dark blue font on white background (1).png
Illumina and Syapse Partner on Research to Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices
January 04, 2022 09:00 ET | Syapse
SAN FRANCISCO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today...
SYA dark blue font on white background (1).png
Syapse Recognized by Comparably Awards Across Four Categories
December 17, 2021 10:00 ET | Syapse
SAN FRANCISCO, Dec. 17, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today...
SYA dark blue font on white background (1).png
Bayhealth Collaborates with Syapse, Bringing Data-Driven Approach to Oncology Care
December 15, 2021 10:00 ET | Syapse
SAN FRANCISCO and DOVER, Del., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing...
SYA dark blue font on white background (1).png
Syapse Announces New Studies Published at Virtual ISPOR Europe 2021
December 06, 2021 11:00 ET | Syapse
SAN FRANCISCO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
SYA dark blue font on white background (1).png
Syapse Senior People Manager Recognized as 2021 WellBeyond Leader of the Year for Emerging Companies While the Company Takes Home Three Comparably Awards
October 13, 2021 09:00 ET | Syapse
SAN FRANCISCO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-word evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real world care, today...
SYA dark blue font on white background (1).png
Syapse Enters Real-World Data Collaboration with Merck to Inform and Improve Cancer Care
October 06, 2021 09:00 ET | Syapse
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-word evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real world care, today...
SYA dark blue font on white background (1).png
Study of Cancer Patients and COVID-19 Highlights Health Disparities
July 22, 2021 08:30 ET | Syapse
DETROIT, July 22, 2021 (GLOBE NEWSWIRE) -- Findings from a study led by researchers at Henry Ford Cancer Institute, in collaboration with Advocate Aurora Health, the Food and Drug Administration and...
logo big square.png
Syapse Announces New Real-World Data Studies Published at 2021 American Society for Clinical Oncology Annual Meeting
June 03, 2021 09:00 ET | Syapse
SAN FRANCISCO, June 03, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-word evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real world care, today...
logo big square.png
Syapse Showcases Real-World Mortality Data in American Society of Clinical Oncology’s JCO-CCI
April 09, 2021 09:00 ET | Syapse
SAN FRANCISCO, April 09, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, today...
logo big square.png
Syapse Expands Strategic Collaboration with Pfizer Focusing on Real-World Evidence
March 10, 2021 10:00 ET | Syapse
Through the Syapse Learning Health Network™, Pfizer will Generate Insights to Advance Cancer Outcomes Research SAN FRANCISCO, March 10, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world...